NCT05349019 - A Natural History Study of Patients With G2019S LRRK2 Parkinson's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

May 2, 2022

Primary Completion Date

August 5, 2022

Study Completion Date

August 5, 2022

Conditions

Patients With Parkinson's Disease (PD) Caused by the p.Gly2019Ser (G2019S) Pathogenic Mutation of the Leucine-Rich Repeat Kinase 2 (LRRK2) Gene

Interventions

OTHER

Observational

This is an observational study to investigate the natural history of G2019S LRRK2 PD using traditional and digital methodology (digital phenotyping). Study conduct will be decentralized (at home as much as possible) consisting of two parts: Part A with Healthy Volunteers (HV) participants and Part B in patients with G2019S LRRK2 PD.

Trial Locations (1)

90230

Science 37, Culver City